Careers

Want to make a difference in Canada’s healthcare system?

Innovative Medicines Canada is the voice of Canada’s innovative pharmaceutical industry. We believe in ensuring Canadians have access to the treatments they need, when they need them. Our work is a fundamental part of safeguarding our healthcare system for future generations. We encourage our members to focus on what matters: delivering better healthcare solutions to Canadians.

Innovative Medicines Canada posts relevant job opportunities from entry-level positions to leadership team openings. We do not recruit on behalf of our members and/or industry partners, so contact about a posted position should be based on the information contained in the job posting. Members and/or industry partners interested in leveraging the Innovative Medicines Canada website as part of their recruitment efforts can contact Alison Sargent, Executive Director, Engagement, at asargent@imc-mnc.ca or 613-236-0455 ext. 219.

Positions at Innovative Medicines Canada

  • No postings available

Positions at Innovative Medicines Canada member companies

Industry-related positions

The Petri Dish

BioTalent Canada is the HR partner of Canada’s pharmaceutical industry. As an HR expert and national non-profit organization, BioTalent Canada focuses on building partnerships and skills for Canada’s pharmaceutical industry to ensure the industry has access to job-ready people.

Innovative Medicines Canada is a Platinum Partner of BioTalent Canada allowing Innovative Medicines Canada members access to discounted job postings on The PetriDishTM job board and other corporate discounts.

The PetriDishTM allows employers to easily post and manage jobs on Canada’s only national, bilingual, biotech job board. The PetriDish caters exclusively to the hiring needs of bio-economy employers, including pharmaceuticals, so job postings will not be lost in the noise of other industries.

For more information, please contact Fiorella Jansen-Nicorescu at fnicorescu@biotalent.ca or 613-235-1402 extension 229.